Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Theratechnologies gets special protocol assessment for HIV trial
Theratechnologies launched its TH9507 pivotal phase III program in March 2005. The first 412-patient clinical trial began in June 2005 and patient enrolment at 43 clinical sites across
Theratechnologies launched its TH9507 pivotal phase III program in March 2005. The first 412-patient clinical trial began in June 2005 and patient enrolment at 43 clinical sites across
Barr’s three year battle to sell the drug over-the-counter has caused considerable controversy in the US with some groups claiming that easier access to the drug would promote
Teva said this step is designed to further improve efficiencies, supply chain management and competitive positioning following the company’s $7.4 billion acquisition of Ivax in January 2006. Through
If the proof is validated, it will solve the ages-old mystery of what provokes black pigment gallstones, and, Nanobac hopes, forge a path to effective early diagnosis and
Many pregnant women get prescriptions for non-steroidal anti-inflammatory drugs (NSAIDs) during their first trimester, and even more – up to 15% – take over-the-counter versions of these drugs.
In the study, 21 patients were treated to evaluate the safety of the regimen and to determine the maximum tolerated dose of Xyotax (paclitaxel poliglumex) in combination with
Keppra (levetiracetam) is widely prescribed as an add-on therapy in the treatment of partial onset seizures in adults and children four years of age and older with epilepsy.
Current methods of generating embryonic stem cells involve removing the cells from a roughly five-day-old embryo, destroying the embryo in the process. Because of moral concerns about the
The study, which did not include a placebo arm, found that after 12 weeks of treatment, patients in both the Mirapex- and sertraline-treated groups achieved a significant improvement
A recently completed phase I clinical trial in healthy volunteers evaluated an intravenous formulation of the drug candidate. Pharmacokinetic data from that trial suggest that the half-life of